Dbv Technologies operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other
pharmaceutical manufacturers in Europe:
sales of 9.51 million Euro [US$11.76 million]
Amryt Pharma PLC
of the United Kingdom
(£11.18 million [US$15.97 million]
Replek AD Skopje
based in Macedonia
(955.23 million Denar [US$19.18 million]
Dbv Technologies reported sales of 11.91 million Euro (US$14.74 million)
December of 2017.
increase of 31.1%
versus 2016, when the company's sales were 9.08 million Euro.
Sales at Dbv Technologies have increased during each of the previous five years
(and since 2012, sales have increased a total of 329%).